12 March 2020

Blueberry Therapeutics announces new Clinical Science Lead

Blueberry Therapeutics are delighted to welcome Kerry Nield as Clinical Science Lead, with responsibility for clinical trial design and pipeline implementation including clinical scientific expertise, clinical strategy and product development planning.

Kerry has over 17 years’ experience in pharmaceutical and clinical development with a particular focus in dermatology, and has previously held senior positions at Renovo, and more recently, Smerud Medical Research. Kerry has a PhD in Molecular Genetics from the University of Manchester and a BSc (Hons) in Human Genetics from University College London.

From our portfolio

Cerebrum Matter

Digital Healthcare Technology

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300